دورية أكاديمية

S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA.

التفاصيل البيبلوغرافية
العنوان: S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA.
المؤلفون: Scully, Marie, Baptista, Jovanna, Bhattacharya, Indranil, Cataland, Spero, Coppo, Paul, Cuccia, Loredana, Dutt, Tina, Susan Huang, Shih-Han, Pascual Izquierdo, Cristina, Eva Mingot-Castellano, María, Parnes, Aric, Pavenski, Katerina, Rajavel, Kavitha, Jarque, Isidro, Wang, Linda T., Fernández Zarzoso, Miguel, Zhu, Andy, Mellgård, Björn
المصدر: HemaSphere; 2023 Supplement 3, Vol. 7, pe8651306-e8651306, 1p
قاعدة البيانات: Complementary Index
الوصف
تدمد:25729241
DOI:10.1097/01.HS9.0000968132.86513.06